To provide an overview on the present understanding of roles of oxidative DNA damage repair in cell signaling underlying bronchoconstriction common to, but not restricted to various forms of asthma and chronic obstructive pulmonary disease.
INTRODUCTION
Exposures of airways to chemicals, gases, particulates and biological agents, shear stress, and sudden temperature and osmotic changes generate cascade of events and mediators to trigger sensory neuronal signals, which are transmitted to the afferent parasympathetic autonomic nervous system leading to constriction of airway smooth muscle (ASM) [1 && ,2-8]. The resulting clinical symptoms include wheezing, chest tightness, shortness of breath, and dyspnea and are features of asthma, chronic pneumonitis, chronic obstructive pulmonary disease (COPD), and chronic bronchitis [9] [10] [11] [12] [13] [14] [15] . In severe cases, the airway narrowing can be fatal [16] . Narrowing of air passages may occur among healthy individuals such as that observed during physical activities [17, 18] . Common to all environmental stimuli is increased generation of reactive oxygen and nitrogen species, leading to loss of redox homeostases in cells/tissues [19 && ]. Reactive oxygen species (ROS) induce signaling and also cause damage to cellular macromolecules, including genomic and mitochondrial DNA [19 Pathological bronchoconstriction has long been associated with ROS. ROS can be induced directly by exposure of airways to chemicals and particulate matters in smoke (diesel exhaust and cigarette smoke), ozone, NO 2 , and others or biological (e.g. virus infections, allergens, pollens) agents or generated intrinsically. Endogenous sources are metabolic processes, dysfunctional mitochondria, and membrane-bound oxidoreductases (e.g. NADPH oxidases, xanthine oxidase, cytochrome oxidases, lipoxygenases, and others). In ]. Risks of acquiring bronchoconstriction are significantly increased by inhaling oxidizing pollutants or those which induce oxidative stress in the airways [29, 30] ; for example, ozone is a principal mediator of bronchoconstriction in the lungs [31] . Ozone exposure increases the levels of reactive species in the airway lining fluid and mucosal epithelial cells, as shown by enhanced levels of H 2 O 2 , 4-hydroxy-2-nonenal (4-HNE), and isoprostanes [31] [32] [33] [34] . 4-HNEs are potent signaling species that, along with isoprostane, directly induce the contraction of cultured bronchial ASM and induce airflow obstruction in an animal model [35, 36] . It has been found that SO 2 , NO 2 , and fine particles (<2.5 mm) in ambient air increase airway oxidative stress and decrease the small airway function, especially in asthmatic children [37] . Inhaled pollen grains and subpollen particles, because of their intrinsic NADPH oxidase activity, increase ROS (H 2 O 2 and 4-HNE), decrease GSH levels in the lung epithelium and airway lining fluid, and increase airway hyperresponsiveness and innate and allergic inflammatory responses [38] [39] [40] [41] .
The complexity of the molecular mechanisms of bronchoconstriction is further underlined by a wide range of mediators that are generated by various cell types [airway epithelium, resident macrophages, mast cells, and inflammatory cells (neutrophils and eosinophils)] surrounding the ASM layer of airway passages. Thus, the molecular mechanism by which a variety of agents induce ASM contraction is not fully understood; however, it is quite clear that ROS signaling and oxidative modifications to molecules are significant players. In support of the cause of ROS in bronchoconstriction is that antioxidant (N-acetyl-L -cysteine and vitamin C)-mediated increases in pulmonary antioxidant capacity improve lung function, as defined by randomized, double-blind, placebo-controlled studies [42] [43] [44] .
KEY POINTS
Pathological constriction of smooth muscle is one of the causes of airway narrowing in patients with atopic, nonatopic asthma, and COPDs.
Bronchoconstriction is resulting from a complex interplay among mucosal epithelium, mast cells, smooth muscles, and parasympathetic nervous system.
All triggers of bronchoconstriction change cellular redox balance, resulting in ROS signaling, and DNA damage and repair.
DNA repair-linked signaling-driven gene expression primes contributing cells and is directly involved in shortening muscle filaments.
Elucidating the DNA damage-repair driven signaling pathways will aid in identifying novel targets to treat and prevent nonphysiological bronchoconstriction.
ROS oxidize DNA bases and thus generate abasic sites, single-strand breaks, and double-strand breaks [45] [46] [47] . Among nucleic acid bases, guanine possessing the lowest oxidative potential [48, 49] is one of the most frequent oxidative targets, and the modified guanine base most often is 8-oxo-7,8-dihydro-2 0 -deoxyguanosine (8-oxoG) [50, 51] . ROS also induce damage to other DNA and RNA bases, including 2-hydroxy adenine, 8-oxoadenine, 5-hydroxycytosine, cytosine glycol, and thymine glycol [52] .
Genomic 8-oxoG is considered one of the best biomarkers of oxidative stress [53] and correlates closely with the dose and length of exposure, as well as the physical nature of the inhaled agents/ oxidants [54] [55] [56] ; for example, 8-oxoG levels are increased in the DNA of lung epithelial cells, resident macrophages, and peripheral blood monocytes, together with a rise in exogenomic 8-oxoG (or 8-oxoG) levels in body fluids (e.g. serum, urine, sputum, bronchoalveolar lavage) upon exposure to environmental pollutants [56] [57] [58] [59] [60] . To prevent mutations and maintain genomic integrity, DNA is subjected to repair via various pathways (base excision, nucleotide excision; single and doublestrand repair pathways) [23, 61, 62] . The repair of 8-oxoG is carried out via 8-oxoguanine DNA DNA Ligase III/XRCC1 DNA DAMAGE REPAIR BY 8-OXOGUANINE DNA GLYCOSYLASE1: ACTIVATION OF CELL SIGNALING OGG1, in addition to being a canonical DNA BER protein in the nuclear compartment, also is found in the cytoplasm and often colocalizes with microtubule organizing centers, microtubule networks, and mitotic chromosomes [63] [64] [65] , and is claimed to be an important modulator of cell division. Deficiency in OGG1 activity in 8-oxoguanine DNA glycosylase1 gene (Ogg1) knockout (Ogg1 À/À ) mice has resulted in a decreased inflammatory response to challenge by bacterial infections or proinflammatory agents [66] [67] [68] [69] implying that OGG1 and/or 8-oxoG base (product of OGG1-BER) are components of proinflammatory signaling. Mechanistic studies have shown that the 8-oxoG base released during DNA-BER forms a complex with a cytoplasmic OGG1 (OGG1 : 8-oxoG) (Fig. 1) . ]. These data imply that OGG1 : 8-oxoG is a functional guanine nucleotide exchange factor (OGG1-GEF). It has been shown that OGG1-BER in the airway epithelium has activated Kirsten (K)-RAS, which increases the levels of phosphorylated (p)-Raf proto-oncogene serine/threonine protein kinase, p-mitogenactivated protein kinase kinase, p-extracellularsignal-regulated kinases 1/2, p-mitogen and stress activated protein kinase-1, and also p-phosphoinositide 3-kinase(p85), a downstream activator of the serine/threonine kinase [74 && ,75] . These kinases phosphorylate Rel avian reticuloendotheliosis viral oncogene homolog A (RelA) at serine 276 , which allows its nuclear translocation, complex formation with nuclear factor-kappaB (NF-kB)-p50, binding to its motif as well as its interaction with members of transcriptional machinery and RNA pol II in promoters for prompt gene expression [76, 77] . Activated small GTPases-driven signaling also induces expression of regulatory and structural proteins and 'priming' the cellular network for bronchoconstriction of the conducting airways (Figs 2 and 3 ).
8-OXOGUANINE DNA GLYCOSYLASE1-DRIVEN DNA BASE EXCISION REPAIR-DEPENDENT GENE EXPRESSION PRIMES CELLS FOR BRONCHOCONSTRICTION
To examine a potential role of OGG1-BER in airway narrowing, we challenged parallel groups of mice with OGG1-BER product 8-oxoG base repeatedly to mimic the continuous repair of DNA by OGG1. RNAs were isolated after the last challenge at 0, 30, 60, and 120 min ( Fig. 2a ) [78 & ,79 && ]. In controls, lungs were challenged once and RNAs were isolated at the same time points ( Fig. 2a ). Changes in gene expression were determined by RNA sequencing (RNA-Seq; Gene Expression Omnibus Series accession number: GSE61095 and GSE65031), and the data were analyzed by gene ontology (GO) and statistical tools. A single exposure of airways to 8-oxoG induced gene expressions primarily related to the immune system; macrophage activation, mediated by chemokines, cytokines, and integrin; and interleukin signaling pathways [79 && ]. In contrast, repeated challenge induced gene expression potentially involved in modulation of the actin family cytoskeleton, extracellular matrix, cell adhesion, cell junction, and cell communication.
To test whether these gene products could 'prime' airway tissues for strenuous bronchoconstriction, first we assembled a list of genes that are documented to be involved in ASM constriction by using the GeneCards database. These genes were 'overlaid' on data sets from RNA sequencing. The overlapping genes were hierarchically clustered and heat maps were generated using GENE-E online software from Broad Institute (Cambridge, MA, USA) for visual presentation of gene expression ( Fig. 2b) . Although we show results of gene expression from the 0, 30, 60, and 120 min time points, for further analysis, we have chosen data collected at 60 min, because at 120 min, high levels of de novo synthesized mediators [TNFa, chemokine (C-X-C motif) ligand 1,2 (CXCL1,2), chemokine (C-C motif) ligand 20 (CCL20) and chemokine (C-X-C motif) ligand 5 (CXCL5)] were present in bronchoalveolar lavage fluid [74 && ,75] . Activating OGG1' GEF activity with 8-oxoG resulted in upregulation of 39 genes out of 79 contributing to bronchoconstriction, and only 10 were downregulated (Fig. 2b) . Upregulated genes (!five-fold) included several associated with ASM and endothelial cell function (e.g. M3 muscarinic acetylcholine receptor, vasoactive intestinal peptide, acetylcholine esterase, tachykinin, endothelin) and inflammation (tumor necrosis factors, chemokine (C-C motif) ligand 11 (CCL11), IL-5, and cyclooxygenase-2). Indeed, an episode of bronchoconstriction is thought to involve overlapping events, such as an increase in intracellular free Ca þþ levels, neural stimulation, vascular leakage, and release of inflammatory mediators [1 && ,2]. We note that OGG1-GEF signaling upregulated the mRNA level of M3 muscarinic acetylcholine receptor (27-fold), which is abundantly expressed on membranes of ASM. Their activation by acetylcholine results in increased levels of GTP-bound guanine nucleotide binding protein, which in turn will hydrolyze phosphatidylinositol 4,5-bisphosphate to diacyl glycerol and inositol trisphosphate. Inositol 1,4,5-trisphosphate increases the release of Ca þþ from sarcoplasmic reticulum. Diacyl glycerol acts as a second messenger that activates protein kinase C, which enhances the sensitivity of the ASM contractile apparatus to Ca þþ . Free cytosolic Ca þþ binds to calmodulin, and the Ca þþ -calmodulin complex activates the enzymatic domain of myosin lightchain kinase, which phosphorylates a specific serine residue of the regulatory myosin light-chain subunit. Light-chain myosin is essential for movement of myosin heads along actin filaments and is responsible for ASM tension [1 && ,80,81]. In controls (single 8-oxoG challenge), tumor necrosis factors and endothelin 1 prostaglandin-endoperoxide synthase 2 were upregulated relevant to bronchoconstriction and 16 genes were downregulated (Fig. 2b) .
Taking system approaches, we examined the association of genes (shown in heat maps, Fig. 2b ) with biological processes Gene Ontology enRIchment anaLysis and visuaLizAtion database (GOrilla; http://cbl-gorilla.cs. technion.ac.il/) [82] was utilized. The GOrilla database defined the most significant is system processes (P ! 10 À7 -10 À9 ) that included neurological system (P > 10 À5 ), sensory perception pain (P > 10 À5 ), sensory perception (P > 10 À5 ), contraction (P > 10 -5 ), regulation of vasoconstriction (P > 10 À5 ), and blood circulation (P > 10 À4 ), among the primary gene ontology categories ( Fig. 2c and d) . It is noteworthy that repeated activation of OGG1' GEF function in lungs is mostly related to the neurological system. In animal models, sensory neuropeptides have been shown to directly modulate bronchial tone, bronchovascular diameter and permeability, and mucus secretions. Thus far, limited human-based evidence supports a role of sensory neuropeptides in bronchoconstriction [83] [84] [85] . In asthmatic study participants, oxidative stress was found to be 
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BRONCHOCONSTRICTION: IMPLICATION OF 8-OXOGUANINE DNA GLYCOSYLASE1-DRIVEN DNA BASE EXCISION REPAIR IN MAST CELL DEGRANULATION
Mast cells infiltrate airway mucosal epithelium and submucosa, including ASM cell layer. In particular, mast cell activation is thought to induce ASM constriction via serotonin, leukotrienes, histamine, and de novo synthesized, lipid-derived factors, cytokines, chemokines, or products of cyclooxygenases [90] http://www.jimmunol.org/content/183/3/1739.long-fn-2.
Studies have examined whether OGG1-GEFmediated activation of gene expression could be linked to mast cell activation and bronchoconstriction changes at mRNA levels (RNA sequencing). GeneCards database showed that 169 gene (!three-fold) documented to be associated with mast cell activation and degranulation among those induced by OGG1-GEF. Genes were hierarchically clustered, and heat maps were generated for visual illustration of the data (Fig. 3a) . Sixty-eight genes were highly upregulated (!five-fold) and 12 downregulated. The most upregulated (!10-fold) are closely associated with mast cell degranulation, including for example, phospholipase Cg1, phospholipase A2, phospholipase D1, tumor necrosis factors, GRB2-associated binding protein. In the lungs of control animals (single 8-oxoG challenge), only eight out of 169 genes were upregulated, and 11 genes were downregulated (Fig. 3a) . The GOrilla gene ontology analysis tool has identified mast cell activation-associated biological processes, driven by up and downregulated genes (p ! 10 -5 to ! 10 -9 ) (Fig. 3b ). These include regulation of cell activation, leukocyte, immune effecter process, exocytosis (P > 10 -5 to 10 -7 ), positive regulation mast cell activation, immune system process, leukocyte-mediated immunity, regulation of mast cell activation involved in the immune response and of the regulated secretory pathway, and leukocyte degranulation (P values > 10 -7 and 10 -9 ). Importantly, the P value of the regulation of mast cell degranulation process was <10 -9 , strongly implying a role of OGG1-GEF-mediated signaling pathways and gene expression in priming mast cells for degranulation.
Classical activation of mast cells is mediated by the high-affinity receptor for IgE resulting in exocytosis of cytoplasmic granules (containing preformed mediators) [91] . In addition to high-affinity receptor for IgE-mediated signals, exposure to ROS added extrinsically or generated by oxidoreductases associated with various intracellular membranes and mitochondria can also lead to the release of mast cell mediators [92] [93] [94] . An intriguing question was whether transient silencing of OGG1 expression affects the degranulation of mast cells. To do so, we exposed Ogg1-depleted, nonsensitized (without sensitization with IgE antibodies) RBL-2H3 cells to glucose oxidase to generate ROS and DNA damage (primarily 8-oxoG) [74 && ]. In OGG1-deficient RBL-2H3 cells, the release of biogenic amines (histamine and serotonin) was significantly decreased compared with that of OGG1-expressing ones ( Fig. 3c  and d ). Silencing OGG1 expression had no effect on ionomycin (an ionophore, raises intracellular Ca þþ levels)-induced release of histamine and serotonin (data not shown). To traffic the secretory vesicles to the plasma membrane of mast cells to release their contents requires small GTPase RAC1 for mobilization of Ca þþ and cytoskeletal rearrangement [95, 96] . These data together with OGG1-GEF-mediated activation of RAC1 in response to ROS [72] imply that OGG1 could also be a rate-limiting protein in mast cell degranulation.
CONCLUSION
Major progress has been made in understanding the pathophysiology of unwanted bronchoconstriction resulting in severe airflow limitations in patients with asthma and COPD; however, molecular events that prime contributing cells to generate smooth muscle-reacting mediators are unclear. The underlying mechanisms are complex because of a large variety of stimuli and the interplay among airway mucosal epithelium, submucosal tissues (mast cells, smooth muscle, inflammatory cells, and sensory and motor neurons) and the vascular system of the lungs. The genetic background of susceptible individual and epigenetic changes adds an additional layer of complexity. Recent studies show that the repair of oxidatively damaged DNA can result in GEF activity of OGG1 (OGG1-GEF), which activates small GTPases, and thereby induces gene expression that 'primes' the mucosal epithelium and submucosal tissues to generate mediators of ASM contraction in conducting airways. Moreover, OGG1-GEF via activation of RHO family small GTPases directly contributes to mediator release from cells and mobilization of intracellular filaments thereby to ASM contraction. Although, additional studies are required, the data presented here point to a novel paradigm -a potential role of OGG1-BER in the priming of mucosal and submucosal cells to induce ASM tension. 
